The Federal Trade Commission has given Lockheed Martin the go-aheadto buy Loral on the condition that it take measures to limit thepossibility of antitrust conflicts in the defense industry. TheFTC's concerns had delayed the consummation of the merger,
The Federal Trade Commission has given Lockheed Martin the go-ahead
to buy Loral on the condition that it take measures to limit the
possibility of antitrust conflicts in the defense industry. The
FTC's concerns had delayed the consummation of the merger, which
was announced earlier this year (SCAN 1/17/96).
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.